BioMarin Pharmaceutical Inc. (BMRN) Granted Accelerated Assessment of Roctavian - Truist Securities
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street rallies after Democrats win Congress; data center stocks slide
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
| BioMarin Pharmaceuticals, Inc. (NASDAQ: BMRN) | Delayed: 56.48 +0.82 (1.47%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $55.66 | 52 Week High | $108.96 | |||
| Open | $56.60 | 52 Week Low | $62.12 | |||
| Day High | $57.39 | P/E | N/A | |||
| Day Low | $55.67 | EPS | $-1.27 | |||
| Volume | 937,879 | |||||
